Facilitation of TRKB Activation by the Angiotensin II Receptor Type-2 (AT2R) Agonist C21.

Laukkanen, Liina; Diniz, Cassiano R A F; Foulquier, Sebastien; Prickaerts, Jos; Castrén, Eero; Casarotto, Plinio C

Laukkanen, Liina; Diniz, Cassiano R A F; Foulquier, Sebastien; Prickaerts, Jos; Castrén, Eero; Casarotto, Plinio C.

Afiliação

Laukkanen L; Neuroscience Center, HiLife, University of Helsinki, 00014 Helsinki, Finland.
Diniz CRAF; Department of Pharmacology, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto 14049-900, SP, Brazil.
Foulquier S; Department of Pharmacology and Toxicology, CARIM-School for Cardiovascular Diseases, MHeNS-School for Mental Health and Neuroscience, Maastricht University, 6229 ER Maastricht, The Netherlands.
Prickaerts J; Department of Psychiatry and Neuropsychology, MHeNS-School for Mental Health and Neuroscience, Maastricht University, 6229 ER Maastricht, The Netherlands.
Castrén E; Department of Psychiatry and Neuropsychology, MHeNS-School for Mental Health and Neuroscience, Maastricht University, 6229 ER Maastricht, The Netherlands.
Casarotto PC; Neuroscience Center, HiLife, University of Helsinki, 00014 Helsinki, Finland.

Pharmaceuticals (Basel) ; 14(8)2021 Aug 06.

Article em En | MEDLINE | ID: mdl-34451870

Palavras-chave

angiotensin 2 type 2 receptor (AT2R); compound 21; fear conditioning; neurotrophin receptor type 2 (NTRK2); renin-angiotensin system (RAS)

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Finlândia País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google